Large gap with delayed quotes
|
Last quote
02/02/2026
-
22:15:00
|
Bid
02/02/2026 -
22:00:00
|
Bid Volume |
Ask
02/02/2026 -
22:00:00
|
Ask Volume |
|---|---|---|---|---|
|
93.83
-0.70
(
-0.74% )
|
93.78
|
2,600 |
93.83
|
7,500 |
Analysis date: 30.01.2026
Global Evaluation
Slightly positive
Slightly positive
The stock is classified in the slightly positive zone since 23.01.2026.
Interest
Strong
Strong
Three stars since 27.01.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 23.01.2026 at a price of 98.40.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Negative
Negative
The stock appears oversold from a technical perspective due to its recent losses. It trades below its forty day technical trend since 31.10.2025.
4wk Rel Perf
-12.15%
-12.15%
The stock appears oversold from a technical perspective, with a four week dividend-adjusted underperformance of of 12.15% behind the SP500.
Sensibility
Low
Low
Low, no change over 1 year.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.43%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.31%.
Mkt Cap in $bn
9.51
9.51
With a market capitalization >$8bn, ENCOMPASS HEALTH is considered a large-cap stock.
G/PE Ratio
0.84
0.84
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
15.06
15.06
The estimated PE is for the year 2027.
LT Growth
11.81%
11.81%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
10
10
Over the last seven weeks, an average of 10 analysts provided earnings per share estimates.
Dividend Yield
0.80%
0.80%
The twelve month estimated dividend yield represents 12.11% of earnings forecasts.
Beta
62
62
For 1% of index variation, the stock varies on average by 0.62%.
Correlation
0.43
0.43
42.58% of stock movements are explained by index variations.
Value at Risk
5.68
5.68
The value at risk is estimated at USD 5.68. The risk is therefore 6.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.12.2011
02.12.2011